Application 077790
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FLUDARABINE PHOSPHATE | FLUDARABINE PHOSPHATE | INJECTABLE;INJECTION | 50MG/VIAL | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077790-001 | FLUDARABINE PHOSPHATE | FLUDARABINE PHOSPHATE | 50MG/VIAL | INJECTABLE / INJECTION | 2007-04-06 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A077790-001 | FLUDARABINE PHOSPHATE | 50MG/VIAL | INJECTABLE / INJECTION | 2007-04-06 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A077790-001 | FLUDARABINE PHOSPHATE | 50MG/VIAL | INJECTABLE / INJECTION | 2007-04-06 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A077790-001 | FLUDARABINE PHOSPHATE | 50MG/VIAL | INJECTABLE / INJECTION | 2007-04-06 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A077790-001 | FLUDARABINE PHOSPHATE | 50MG/VIAL | INJECTABLE / INJECTION | 2007-04-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A077790-001 | AP | 1 | 74a2ff9319b5… |
| 2021-12-28 21:50 UTC | 2021-12 | A077790-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A077790-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A077790-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A077790-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A077790-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A077790-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A077790-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A077790-001 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fludarabine | FLUDARABINE PHOSPHATE | Fresenius Kabi USA, LLC | cf5255cc-91fd-4132-973b-764dba142eae | 2024-10-14 | Boxed warning, Warnings, Adverse reactions | FLUDARABINE PHOSPHATE |
| Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Areva Pharmaceuticals | 8039c2e3-ffe5-3997-e053-2991aa0ad9d0 | 2023-02-14 | Boxed warning, Warnings, Adverse reactions | Fludarabine Phosphate FLUDARABINE PHOSPHATE |
| Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Lannett Company, Inc. | 0170c0f4-d502-4f8f-bdbf-6439f3ed33fb | 2023-01-31 | Boxed warning, Warnings, Adverse reactions | Fludarabine Phosphate FLUDARABINE PHOSPHATE |
| Fludarabine phosphate | FLUDARABINE PHOSPHATE | Actavis Pharma, Inc. | 3adca34b-4f65-4e21-8058-3c01fc7fc9bb | 2022-09-30 | Boxed warning, Warnings, Adverse reactions | Fludarabine phosphate FLUDARABINE PHOSPHATE |
| Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Sagent Pharmaceuticals | 20e5acf0-90b7-45c8-be78-91eaf77c9ac0 | 2021-07-22 | Boxed warning, Warnings, Adverse reactions | Fludarabine Phosphate FLUDARABINE PHOSPHATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 61703-344 | Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Hospira, Inc. | ANDA | Current |
| 61703-344 | Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Hospira, Inc. | ANDA | Current |
| 61703-344 | Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Hospira, Inc. | ANDA | Current |